Pharmaceutical dosage unit for treating inflammation comprising

Details Pharmaceutical dosage unit for treating inflammation comprising Pharmaceutical dosage unit for treating inflammation comprising

1992-11-23

1994-07-05

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

424 941, 424 9463, 424 946, A61K 37547, A61K 3748, A61K 3754

Patent

active

053265629

ABSTRACT:
Methods and pharmaceutical compositions for treatment of inflammation and arthritis using protease nexin-I as an active ingredient are disclosed.

REFERENCES:
patent: 5006252 (1991-04-01), Scott et al.
patent: 5112608 (1992-05-01), Scott et al.
McGuire-Goldring et al., Arthritis & Rheumatism, p. S24, abstract #51 (1984).
Baker et al., J. of Cellular Physiology, vol. 112, (1982), pp. 291-297.
Conn, P. (ed), The Receptors, vol. III, published by Academic Press Inc., "Protease Nexins: Secreted Protease Inhibitors that Regulate Protease Activity at or Near the Cell Surface," chapter 5, pp. 153-172 (1986).

Affiliated with

Also associated with

Rating

Pharmaceutical dosage unit for treating inflammation comprising does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical dosage unit for treating inflammation comprising , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical dosage unit for treating inflammation comprising will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-794943